Covestor’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$72K Sell
6,221
-5,509
-47% -$68.7K 0.05% 469
2025
Q4
$134K Buy
11,730
+2,844
+32% +$33.4K 0.07% 398
2025
Q3
$113K Sell
8,886
-150
-2% -$2.18K 0.06% 511
2025
Q2
$143K Sell
9,036
-742
-8% -$11.1K 0.08% 344
2025
Q1
$146K Buy
9,778
+1,456
+17% +$25.8K 0.1% 266
2024
Q4
$158K Buy
8,322
+1,081
+15% +$22.9K 0.1% 269
2024
Q3
$196K Buy
7,241
+1,965
+37% +$50.2K 0.12% 181
2024
Q2
$131K Buy
5,276
+2,203
+72% +$63.2K 0.08% 341
2024
Q1
$102K Buy
3,073
+723
+31% +$24.7K 0.06% 531
2023
Q4
$84K Buy
2,350
+893
+61% +$28.3K 0.06% 603
2023
Q3
$50K Buy
1,457
+176
+14% +$6.69K 0.04% 777
2023
Q2
$51K Sell
1,281
-1,770
-58% -$70.4K 0.04% 774
2023
Q1
$120K Sell
3,051
-1,515
-33% -$55.6K 0.1% 285
2022
Q4
$145K Buy
4,566
+1,018
+29% +$30.7K 0.12% 235
2022
Q3
$101K Buy
3,548
+177
+5% +$6.05K 0.09% 347
2022
Q2
$120K Buy
3,371
+173
+5% +$7K 0.1% 312
2022
Q1
$157K Buy
3,198
+1,581
+98% +$83.6K 0.1% 255
2021
Q4
$90K Buy
+1,617
New +$88.9K 0.13% 212

Other funds holding XRAY

Covestor's XRAY Position: Q1 2026 in Review

Covestor reduced its Dentsply Sirona (XRAY) stake by 47% in Q1 2026, selling an estimated $68.7K and leaving 6,221 shares worth $72K. The position accounts for 0.05% of the portfolio, ranked #469.

Covestor first reported a position in XRAY in Q4 2021 and has held it in 18 quarters since. The position peaked at $196K in Q3 2024. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

  • Covestor held 6,221 shares of Dentsply Sirona worth $72K as of Q1 2026.
  • Covestor sold 5,509 Dentsply Sirona shares in Q1 2026, an estimated $68.7K.
  • Dentsply Sirona made up 0.05% of Covestor's portfolio in Q1 2026, its #469 holding.
  • Covestor first reported a position in Dentsply Sirona in Q4 2021 and has held it in 18 quarters since.
  • Covestor's Dentsply Sirona position peaked at $196K in Q3 2024.
  • 382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.